Skip to main
BWAY

Brainsway (BWAY) Stock Forecast & Price Target

Brainsway (BWAY) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrainsWay is performing well with its leading position in the TMS market and a strong commercial model, shown through an 83.5% PTSD response rate and a 52% reduction in PCL-5scores in a recent study. With additional evidence supporting its Deep TMS as a versatile technology for various psychiatric and neurological conditions, BrainsWay has a promising pipeline for future growth. While some risks such as inconsistent execution and regulatory delays remain, the potential for additional indications and revenue streams makes BrainsWay a solid investment opportunity.

Bears say

BrainsWay is an established player in the noninvasive neurostimulation market, with a strong focus on recurring revenue and partnerships with mental health clinic networks. With a growing target market and potential for international expansion, the company is primed for continued revenue growth. In addition, recent financial results have exceeded expectations and suggest operational efficiency, leading to a positive buy rating from analysts and a raised price target of $19 per share.

Brainsway (BWAY) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Brainsway and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Brainsway (BWAY) Forecast

Analysts have given Brainsway (BWAY) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Brainsway (BWAY) has a Strong Buy consensus rating as of Sep 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Brainsway (BWAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.